Intermediates
API Category | Product Name | CAS NO. |
Lacosamide | (R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2- ylcarbamate | 880468-89-3 |
Isavuconazonium sulfate | 2-(Methylamino)pyridine-3-methanol | 32399-12-5 |
4-(2-Bromoacetyl)benzonitrile | 20099-89-2 | |
(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyramide | 368421-58-3 | |
(2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1h-1,2,4-triazol-1-yl)butanenitrile | 241479-74-3 | |
(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanamide | 241479-75-4 | |
2-(methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate | 1180002-01-0 | |
Agomelatine | 7-Methoxy-1-naphthylacetonitrile | 138113-08-3 |
7-Methoxy-1-tetralone | 6836-19-7 | |
Cenobamate | 2-Bromo-2'-chloroacetophenone | 5000-66-8 |
1-(2-chlorophenyl)-2-(1,2,3,4-tetrazol-2-yl)ethan-1-one | 1259059-71-6 | |
Minodronic Acid | Ethyl trans-4-oxo-2-butenoate | 2960-66-9 |
Lenalidomide | Methyl 2-methyl-3-nitrobenzoate | 59382-59-1 |
Methyl 2-bromomethyl-3-nitrobenzoate | 98475-07-1 | |
3-Amino-2,6-piperidinedione hydrochloride | 24666-56-6 | |
3-(4-Nitro-1-oxoisoindolin-2-yl)piperidin-2,6-dione | 827026-45-9 | |
Prasugrel HCl | 5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-one hydrochloride | 115473-15-9 |
2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone | 204205-33-4 | |
Cyclopropyl-2-(2-fluorophenyl)ethan-1-one | 150322-73-9 | |
Pitavastatin Calcium | [2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido | 154057-58-6 |
Tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate | 124752-23-4 | |
Ambrisentan | (S)-2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid | 178306-52-0 |
H-PHG-NH2 HCL | 6485-52-5 | |
Tigecycline | Minocycline HCl | 13614-98-7 |
9-Amino Minocycline HCl | 149934-21-4 | |
N-tert-Butylglycine HCl | 6939-23-7 | |
Beraprost sodium | Phosphonic acid, P-(3-methyl-2-oxo-5-heptyn-1-yl)-, diethyl ester | 1542216-62-5 |
(1R,2R,3aS,8bS)-1-formyl-5-(4-methoxy-4-oxobutyl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-2-yl 4-methylbenzoate And its enantiomers | / | |
Alectinib HCL | 2-(4-ethyl-3-iodophenyl)-2-Methylpropanoic acid | 1256584-73-2 |
4-(Morpholin-4-yl)-piperidine dihydrochloride | 550370-31-5 | |
Brexpiprazole | 7-(4-Chlorobutoxy)-1H-quinolin-2-one | 913613-82-8 |
1-(Benzo[b]thiophen-4-yl)piperazine | 846038-18-4 | |
Risdiplam | 4,7-Diazaspiro[2.5]octane-4-carboxylic acid, 7-[2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-7-yl]-, 1,1-dimethylethyl ester | 2133298-74-3 |
6-Chloro-4-Methylpyridazin-3-Amine | 64068-00-4 | |
Givinostat | 4-[[6-[(Diethylamino)methyl]-2-naphthalenyl]methoxy]carbonyllamino]benzcic acid | 199657-47-1 |
Mirdametinib | Mirdametinib Intermediate | 391212-52-5 |
(4R)-2,2-dimethyl-[1,3]dioxolan-4-ylmethoxyamine | 114778-50-6 | |
2-(2-Fluoro-4-iodoanilino)-3,4-difluorobenzoic Acid | 391211-97-5 | |
Momelotinib | 4-(2-(4-MorpholinophenylaMino)pyriMidin-4-yl)benzoic acid | 945749-71-3 |
Brigatinib | 2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline | 761440-75-9 |
(2-((2,5-Dichloropyrimidin-4-yl)amino)phenyl)dimethylphosphineoxide | 1197953-49-3 | |
Vismodegib | 2-Chloro-4-methylsulphonylbenzoic acid | 53250-83-2 |
2-(2-Chloro-5-nitrophenyl)pyridine | 879088-40-1 | |
Dabrafenib | N-{3-[5-(2-chloro-4-pyriMidinyl)-2-(1,1-diethylethyl)-1,3-thiazol-4-yl]-2-fluoraphenyl}-2,6-difluorobenzenesulfonaMide | 1195768-23-0 |
N-(3-(2-bromo-2-(2-chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide | 1622082-84-1 | |
Tolvaptan | 1-(4-Amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | 137977-97-0 |
Customized Products | 2-Fluoroadenine | 700-49-2 |
Tianeptine acid | 66981-73-5 | |
7-Amino-heptanoic acid ethyl ester hydrochloride | 29840-65-1 | |
3-Aminobenzoic acid | 99-05-8 | |
2,2'-Anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride | 10212-25-6 | |
Iron saccharate | 8047-67-4 | |
Disclaimer:
- This list of products and reference to any product herein should not be construed and/or constituted transaction where it is not permitted underpatent law of the country and/or
is not authorized by other laws and regulations of the country. - All the products under the patent are only for R&D use.